0001140361-18-018863.txt : 20180417
0001140361-18-018863.hdr.sgml : 20180417
20180417202259
ACCESSION NUMBER: 0001140361-18-018863
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180416
FILED AS OF DATE: 20180417
DATE AS OF CHANGE: 20180417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murray Mark J.
CENTRAL INDEX KEY: 0001628383
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 18760095
MAIL ADDRESS:
STREET 1: C/O ARBUTUS BIOPHARMA CORP.
STREET 2: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
4
1
doc1.xml
FORM 4
X0306
4
2018-04-16
0
0001447028
Arbutus Biopharma Corp
ABUS
0001628383
Murray Mark J.
C/O ARBUTUS BIOPHARMA CORP.
SUITE 100, 8900 GLENLYON PARKWAY
BURNABY
A1
V5J 5J8
BRITISH COLUMBIA, CANADA
1
1
0
0
President & CEO
Common Shares
2018-04-17
4
M
0
27007
0.354
A
316396
D
Employee Stock Option (Right to Buy)
5.20
2018-04-16
4
A
0
418187
0
A
2028-04-16
Common Stock
418187
418187
D
Employee Stock Option (Right to Buy)
0.354
2018-04-17
4
M
0
27007
0
D
2008-03-30
2018-03-01
Common Stock
27007
0
D
The options vest as follows: 1/3 on April 16, 2019; 1/3 on April 16, 2020; and 1/3 on April 16, 2021.
Converted from Canadian exercise price of $0.4444; Cdn$1.2552=US$1.00.
Expiration date extended through termination of blackout period.
/s/ Mark J. Murray
2018-04-17